Altered peptide ligands: Prospects for immune intervention in autoimmune disease

Altered peptide ligands: Prospects for immune intervention in autoimmune disease

Veure altres versions (1)

Dades bibliogràfiques
Autor principal:	Fairchild, P
Format:	Journal article
Publicat:	1997

Ítems similars

Altered peptide ligands: prospects for immune intervention in autoimmune disease.
per: Fairchild, P
Publicat: (1997)

Induction of dominant transplantation tolerance by an altered peptide ligand of the male antigen Dby
per: Chen, T, et al.
Publicat: (2004)

Induction of dominant transplantation tolerance by an altered peptide ligand of the male antigen Dby.
per: Chen, T, et al.
Publicat: (2004)

Immune evasion in malaria: altered peptide ligands of the circumsporozoite protein.
per: Plebanski, M, et al.
Publicat: (1997)

Metabolic alterations of the immune system in the pathogenesis of autoimmune diseases
per: Luz P. Blanco, et al.
Publicat: (2023-04-01)

Metabolic alterations of the immune system in the pathogenesis of autoimmune diseases.
per: Luz P Blanco, et al.
Publicat: (2023-04-01)

Natural altered peptide ligands in HIV infection
per: Klenerman, P, et al.
Publicat: (1996)

Altered peptide ligands narrow the repertoire of cellular immune responses by interfering with T-cell priming.
per: Plebanski, M, et al.
Publicat: (1999)

Epigenetic Alterations in Cellular Immunity: New Insights into Autoimmune Diseases
per: Zijun Wang, et al.
Publicat: (2017-02-01)

A comparative approach linking molecular dynamics of altered peptide ligands and MHC with in vivo immune responses.
per: Bernhard Knapp, et al.
Publicat: (2010-07-01)

Prospect of Gut Microbiota-based Intervention in Autoimmune Disease Control
per: ZHAO Lidan, et al.
Publicat: (2022-09-01)

Nectin Family Ligands Trigger Immune Effector Functions in Health and Autoimmunity
per: Doryssa Hermans, et al.
Publicat: (2023-03-01)

Application and prospect of targeting innate immune sensors in the treatment of autoimmune diseases
per: Jun Liu, et al.
Publicat: (2022-05-01)

Limited in vivo reactivity of polyclonal effector cytotoxic T cells towards altered peptide ligands.
per: Bättig, P, et al.
Publicat: (2005)

Yeast Display for the Identification of Peptide-MHC Ligands of Immune Receptors
per: Huisman, Brooke D, et al.
Publicat: (2023)

Altered peptide ligands trigger perforin- rather than Fas-dependent cell lysis.
per: Bachmann, M, et al.
Publicat: (1997)

Protein and Peptide Array Analysis of Autoimmune Disease
per: William H. Robinson, et al.
Publicat: (2002-12-01)

Quantitative analysis of the T cell receptor signaling network in response to altered peptide ligands
per: Wille, Lucia
Publicat: (2006)

Aberrant Expression of a Proliferation-Inducing Ligand Underlies Autoimmune Mechanisms in Immune Thrombocytopenia
per: Y. F. Hao, et al.
Publicat: (2021-01-01)

Inhibition of TCR triggering by a spectrum of altered peptide ligands suggests the mechanism for TCR antagonism.
per: Bachmann, M, et al.
Publicat: (1998)

Is an effective immune intervention for Alzheimer's disease in prospect?
per: Esiri, M
Publicat: (2001)

Altered peptide ligands induce quantitatively but not qualitatively different intracellular signals in primary thymocytes.
per: Smyth, L, et al.
Publicat: (1998)

Immunogenic self-peptides - the great unknowns in autoimmunity: Identifying T-cell epitopes driving the autoimmune response in autoimmune diseases
per: Jörg Christoph Prinz
Publicat: (2023-01-01)

The Role and Potential Application of Antimicrobial Peptides in Autoimmune Diseases
per: Chunye Zhang, et al.
Publicat: (2020-05-01)

Antagonism of cytotoxic T lymphocyte-mediated lysis by natural HIV-1 altered peptide ligands requires simultaneous presentation of agonist and antagonist peptides.
per: Sewell, A, et al.
Publicat: (1997)

The effects of natural altered peptide ligands on the whole blood cytotoxic T lymphocyte response to human immunodeficiency virus.
per: Klenerman, P, et al.
Publicat: (1995)

West Nile virus T-cell ligand sequences shared with other flaviviruses: a multitude of variant sequences as potential altered peptide ligands.
per: Jung, K, et al.
Publicat: (2012)

Tuning antiviral CD8 T-cell response via proline-altered peptide ligand vaccination.
per: Adil Doganay Duru, et al.
Publicat: (2020-05-01)

Human antimicrobial peptides in autoimmunity
per: Ekaterina S. Umnyakova, et al.
Publicat: (2020-04-01)

Glycoprotein Pathways Altered in Frontotemporal Dementia With Autoimmune Disease
per: Fiona Bright, et al.
Publicat: (2021-09-01)

On the role of the innate immunity in autoimmune disease.
per: Bachmann, M, et al.
Publicat: (2001)

Immune regulation and immunotherapy in autoimmune disease /
per: Zhang, Jingwu, 1956-, et al.
Publicat: (2007)

Immune-Neuroendocrine Interactions and Autoimmune Diseases
per: Luis J. Jara, et al.
Publicat: (2006-01-01)

Mass Cytometry Studies of Patients With Autoimmune Endocrine Diseases Reveal Distinct Disease-Specific Alterations in Immune Cell Subsets
per: Louise Magnusson, et al.
Publicat: (2020-02-01)

The role of cytokines in the pathogenesis of autoimmune diabetes, immune intervention issues
per: Ye. B. Kravets, et al.
Publicat: (2010-02-01)

Autoimmunity in Chagas' disease: immunomodulation of autoimmune and T. cruzi-specific immune responses
per: Luiz Vicente Rizzo, et al.
Publicat: (1988-11-01)

Altered Metabolic Phenotype of Immune Cells in a Spontaneous Autoimmune Uveitis Model
per: Claudia Barfüßer, et al.
Publicat: (2021-07-01)

AUTOIMMUNE RHEUMATIC DISEASES: RESULTS AND PROSPECTS FOR RESEARCHES
per: E. L. Nasonov, et al.
Publicat: (2015-09-01)

Peptide Targeting of PDZ-Dependent Interactions as Pharmacological Intervention in Immune-Related Diseases
per: Luis H. Gutiérrez-González, et al.
Publicat: (2021-10-01)

Presentation of antigenic peptides by products of the major histocompatibility complex.
per: Fairchild, P
Publicat: (1998)